IL321671A - Method for generating bispecific proteins - Google Patents

Method for generating bispecific proteins

Info

Publication number
IL321671A
IL321671A IL321671A IL32167125A IL321671A IL 321671 A IL321671 A IL 321671A IL 321671 A IL321671 A IL 321671A IL 32167125 A IL32167125 A IL 32167125A IL 321671 A IL321671 A IL 321671A
Authority
IL
Israel
Prior art keywords
antibody
domain
heterodimeric
igg
antibodies
Prior art date
Application number
IL321671A
Other languages
English (en)
Hebrew (he)
Original Assignee
Merus Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merus Nv filed Critical Merus Nv
Publication of IL321671A publication Critical patent/IL321671A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/524—CH2 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/526—CH3 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL321671A 2022-12-27 2023-12-22 Method for generating bispecific proteins IL321671A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2033843 2022-12-27
PCT/NL2023/050681 WO2024144396A1 (en) 2022-12-27 2023-12-22 Method for generating bispecific proteins

Publications (1)

Publication Number Publication Date
IL321671A true IL321671A (en) 2025-08-01

Family

ID=85158672

Family Applications (1)

Application Number Title Priority Date Filing Date
IL321671A IL321671A (en) 2022-12-27 2023-12-22 Method for generating bispecific proteins

Country Status (9)

Country Link
US (1) US20260209390A1 (cg-RX-API-DMAC7.html)
EP (1) EP4642811A1 (cg-RX-API-DMAC7.html)
JP (1) JP2026500710A (cg-RX-API-DMAC7.html)
KR (1) KR20250129720A (cg-RX-API-DMAC7.html)
CN (2) CN121824747A (cg-RX-API-DMAC7.html)
AU (1) AU2023418349A1 (cg-RX-API-DMAC7.html)
IL (1) IL321671A (cg-RX-API-DMAC7.html)
TW (1) TW202432587A (cg-RX-API-DMAC7.html)
WO (1) WO2024144396A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801687A (en) 1986-10-27 1989-01-31 Bioprobe International, Inc. Monoclonal antibody purification process using protein A
US5151504A (en) 1989-11-17 1992-09-29 E. R. Squibb & Sons, Inc. Method for purification of monoclonal antibodies
PT2560993T (pt) 2010-04-20 2024-09-16 Genmab As Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas
IN2014CN03887A (cg-RX-API-DMAC7.html) * 2011-10-27 2015-10-16 Genmab As
CA3094318A1 (en) 2018-03-30 2019-10-03 Merus N.V. Multivalent antibody
EP3966238A2 (en) 2019-05-09 2022-03-16 Merus N.V. Variant domains for multimerizing proteins and separation thereof
CN116462766A (zh) 2020-05-21 2023-07-21 美勒斯公司 用于生产ig样分子的方法和手段

Also Published As

Publication number Publication date
KR20250129720A (ko) 2025-08-29
JP2026500710A (ja) 2026-01-08
AU2023418349A1 (en) 2025-07-03
WO2024144396A1 (en) 2024-07-04
TW202432587A (zh) 2024-08-16
US20260209390A1 (en) 2026-07-23
EP4642811A1 (en) 2025-11-05
CN121824747A (zh) 2026-04-10
CN120641444A (zh) 2025-09-12

Similar Documents

Publication Publication Date Title
Nguyen et al. Functional heavy-chain antibodies in Camelidae
CN114450406B (zh) 一种断裂型内含肽、使用其的重组多肽的制备方法
CA3036912C (en) Antibody specifically binding to pd-1 and functional fragment thereof
JP2021516334A (ja) マイクロチップキャピラリー電気泳動アッセイおよび試薬
JP2019519492A5 (cg-RX-API-DMAC7.html)
CA3236138A1 (en) Anti-cd122 antibodies, anti-cd132 antibodies, and related bispecific binding proteins
JP6506024B2 (ja) 抗体又は抗体組成物の製造方法
CN104011207A (zh) 控制了重链与轻链的缔合的抗原结合分子
JP6866300B2 (ja) タンパク質精製の方法
US20240092899A1 (en) Bispecific antibody
EP3421500A1 (en) Method for expressing and preparing polyvalent multi-specific antibody and immune hybrid protein
US12000839B2 (en) Methods for characterizing disulfide bonds
IL313770A (en) Conditionally active antigen-binding polypeptide complexes and methods of their use
JP2023139186A (ja) 薬剤生成物不純物を特性決定するためのシステム及び方法
JP7482853B2 (ja) アフィニティキャピラリ電気泳動のシステム及び方法
CN121712805A (zh) Ch3结构域变体或包含该ch3结构域变体的双特异性抗体
JP7256172B2 (ja) ミニブタ試料において抗薬物抗体を決定するための方法
JP2026500710A5 (cg-RX-API-DMAC7.html)
JP2019528040A5 (cg-RX-API-DMAC7.html)
CN114716547B (zh) 一种包括抗原结合结构域的结合蛋白及其生产方法和应用
CA3292941A1 (en) Ch3 domain variant or bispecific antibody comprising same
CN120271702A (zh) 一种抗μ珠蛋白的抗体及其应用
JP2025160972A (ja) トランスフェリンレセプターを認識する物質を含む治療剤の用法用量
JP2026515978A (ja) ハイスループットＦａｂ抗体断片の生成及び格付け
JP2026500710A (ja) 二重特異性タンパク質を製造する方法